Table 1:
Baseline characteristics of participants who received false alerts compared to those who received no alerts. Abbreviations: BMI- Body Mass Index; BP- Blood Pressure; COPD- Chronic Obstructive Pulmonary Disease; HR- Heart Rate.
| Socio-demographics | Total (n=80) | Yes (n=10) | No (n=70) | P- value |
|---|---|---|---|---|
| Age, mean, years (SD) | 64.3 (9.1) | 64.9 (9.9) | 64.2 (9.0) | 0.82 |
| Female sex (%) | 34 (42.5) | 4 (40.0) | 30 (42.9) | 1 |
| Race (%) | ||||
| White | 69 (86.3) | 9 (90.0) | 60 (85.7) | 0.33 |
| Other | 11 (13.7) | 1 (10.0) | 10 (14.3) | |
| Married/Living as married (%) | 54 (68.4) | 7 (70.0) | 47 (68.1) | 0.2 |
| Education (%) | ||||
| Less than high school | 2 (2.5) | 0 (0.00) | 2 (2.9) | 0.82 |
| High school degree or some college | 36 (45.6) | 6 (60.0) | 30 (43.5) | |
| College degree | 18 (22.8) | 2 (20.0) | 16 (23.2) | |
| Post-graduate studies/degree | 23 (29.1) | 2 (20.0) | 21 (30.4) | |
| Income (%) | ||||
| Less than 50,000$ annually | 25 (33.8) | 4 (40.0) | 21 (32.8) | 0.96 |
| 50,000 – 99,999$ annually | 23 (31.1) | 3 (30.0) | 20 (31.3) | |
| Over 100,000$ annually | 26 (35.1) | 3 (30.0) | 23 (35.9) | |
| Physiologic parameters | ||||
| BMI, mean (SD) | 32.4 (22.3) | 31.8 (8.0) | 32.5 (23.7) | 0.86 |
| Systolic BP, mean (SD) | 130.4 (15.3) | 134.5 (16.9) | 129.9 (15.1) | 0.37 |
| Diastolic BP, mean (SD) | 76.5 (8.0) | 79.8 (6.5) | 76.0 (8.1) | 0.16 |
| HR, mean (SD) | 72.8 (15.0) | 71.8 (22.9) | 72.9 (13.7) | 0.88 |
| Past Medical History (%) | ||||
| Vascular Disease | 20 (25.0) | 3 (30.0) | 17 (24.3) | 0.7 |
| Valvular Disease | 8 (10.0) | 0 (0) | 8 (11.4) | 0.59 |
| Diabetes Mellitus | 19 (23.8) | 1 (10.0) | 18 (25.7) | 0.44 |
| COPD | 6 (7.5) | 0 (0.0) | 6 (8.6) | 1 |
| Renal disease | 3 (3.8) | 1 (10.0) | 2 (2.9) | 0.33 |
| Major bleeding event or predisposition to bleeding | 5 (6.3) | 1 (10.0) | 4 (5.7) | 0.5 |
| Congestive Heart Failure | 5 (6.3) | 1 (10.0) | 4 (5.7) | 0.5 |
| Essential Hypertension | 62 (77.5) | 8 (80.0) | 54 (77.1) | 1 |
| Obstructive Sleep Apnea | 22 (27.5) | 2 (20.0) | 20 (28.6) | 0.72 |
| Prior myocardial infarction | 14 (17.5) | 2 (20.0) | 12 (17.1) | 1 |
| Hyperlipidemia | 67 (83.8) | 9 (90.0) | 58 (82.9) | 1 |
| Stroke History (%) | ||||
| Stroke | 65 (81.3) | 8 (80.0) | 57 (81.4) | 1 |
| TIA | 22 (27.5) | 4 (40.0) | 18 (25.7) | 0.45 |
| Residual Neurologic Deficits | 27 (33.8) | 2 (20.0) | 25 (35.7) | 0.6 |
| Medication use (%) | ||||
| Anticoagulants | 10 (12.5) | 1 (10.0) | 9 (12.9) | 1 |
| Antiplatelets | 70 (87.5) | 9 (90.0) | 61 (87.1) | 1 |
| Antihypertensives | 45 (56.3) | 3 (30.0) | 42 (60.0) | 0.09 |
| Anti-arrhythmic medications | 2 (2.5) | 0 (0.0) | 2 (2.9) | 1 |
| Beta blockers | 37 (46.3) | 5 (50.0) | 32 (45.7) | 1 |
| Statins | 73 (91.3) | 10 (100.0) | 63 (90.0) | 0.59 |